2016
DOI: 10.1007/s12217-016-9504-y
|View full text |Cite
|
Sign up to set email alerts
|

No Neuromuscular Side-Effects of Scopolamine in Sensorimotor Control and Force-Generating Capacity Among Parabolic Fliers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 46 publications
0
8
0
Order By: Relevance
“…Before flight (30 min), participants were administered scopolamine (0.25 mg/1 mL; 0.7 mL for males and 0.5 mL for females) to prevent motion sickness ( Spinks and Wasiak, 2011 ; Ritzmann et al, 2016 ). The administration of scopolamine does not interfere with sensorimotor skills associated with neuromuscular control ( Ritzmann et al, 2016 ). One participant and the measurement operator had previously experienced MG and HG in parabolic flight.…”
Section: Methodsmentioning
confidence: 99%
“…Before flight (30 min), participants were administered scopolamine (0.25 mg/1 mL; 0.7 mL for males and 0.5 mL for females) to prevent motion sickness ( Spinks and Wasiak, 2011 ; Ritzmann et al, 2016 ). The administration of scopolamine does not interfere with sensorimotor skills associated with neuromuscular control ( Ritzmann et al, 2016 ). One participant and the measurement operator had previously experienced MG and HG in parabolic flight.…”
Section: Methodsmentioning
confidence: 99%
“…Based on the data presented by Ritzmann et al . 27 , which indicate that the medication with Scopolamine does not impede spinal excitability, maximal motor output and neuromuscular performance parameters (balance and jumps), it can be assumed that the injection also does not affect the muscle synergy organization.…”
Section: Methods and Computational Techniquementioning
confidence: 99%
“…Before each flight day, two participants were prepared for the measurements and were given a sex-weight-based injection of 0.2–0.7 ml of Scopolamine 30 min before takeoff to prevent motion sickness (Ritzmann et al, 2016).…”
Section: Methodsmentioning
confidence: 99%